Sept. 18, 2019 Price forecast | 2 weeks: 7.07% | 1 month: 8.20% | 3 months: 11.00% | Premium Forecast


LXRX stock forecast

Our latest prediction for Lexicon Pharmaceuticals, Inc.'s stock price was made on the Sept. 18, 2019 when the stock price was at 3.80$.

In the short term (2weeks), LXRX's stock price should outperform the market by 7.07%. During that period the price should oscillate between -12.12% and +41.97%.

In the medium term (3months), LXRX's stock price should outperform the market by 11.00%. During that period the price should oscillate between -22.86% and +103.93%.


About Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It drug candidates include XERMELO, Sotagliflozin, LX2761, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

At the moment the company generates 43M USD in revenues.

On its last earning announcement, the company reported a loss of -0.84$ per share.

The book value per share is -0.05$

Lexicon Pharmaceuticals, Inc. website


Three months stock forecastSept. 18, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
43M 93.00% -71M -166.10% -89M -0.84 - - 106M -0.05 -102M - -102M